Brand names
Insulin glargine brand names
10 brands in 1 markets
Insulin glargine is sold under 10 brand names in 1 markets in our register data, including BASAGLAR KwikPen, Insulin glargine U-300, Insulin glargine U-300 Max, Langlara, Lantus, Lantus Solostar. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| BASAGLAR KwikPen | United States | Eli Lilly | 100 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Insulin glargine U-300 | United States | Sanofi-Aventis | 300 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Insulin glargine U-300 Max | United States | Sanofi-Aventis | 300 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Langlara | United States | Lanexa Biologics | 100 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Lantus | United States | Sanofi-Aventis | 100 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Lantus Solostar | United States | Sanofi-Aventis | 100 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Rezvoglar KwikPen | United States | Eli Lilly | 100 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Semglee | United States | Biocon Biologics | 100 IU/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Toujeo | United States | Sanofi-Aventis | 300 units/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| TOUJEO Max | United States | Sanofi-Aventis | 300 units/mLInjection | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Insulin glargine for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.